Drug Supply Chain Security Act (DSCSA) Violations
Similar Posts
X3 500K GOLD EDITION may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use X3 500K GOLD EDITION, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug DevelopmentAdvanced Manufacturing Technologies Designation Program
FDA encourages the early adoption of advanced manufacturing technologies (AMTs) that have the potential to benefit patients by improving manufacturing and supply dependability and optimizing development time of drug and biological products.List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic
The FDA maintains a list of approved new drug application (NDA) drug products that are no longer protected by patents or exclusivities, and for which the FDA has not approved an ANDA referencing that NDA drug product.Esophageal pH Monitoring Capsule Recall: Medtronic and Given Imaging Remove Bravo CF Capsule Delivery Devices
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramUPDATE – Albertsons Companies Voluntarily Recalls Select Store-Made Deli Items Containing Bowtie Pasta Supplied by Fresh Creative Foods Due to an Ingredient Recall for Possible Listeria monocytogenes Contamination
Following a recall initiated by Fresh Creative Foods, a division of Reser’s Fine Foods, Inc., Albertsons Companies has voluntarily recalled select store-made deli items, supplied by Fresh Creative Foods, due to possible Listeria monocytogenes contamination. The recall was initiated because these pro